Dr. Appelbaum will discuss findings from a series of focus groups with patients, clinicians, and IRB members on return of polygenic risk scores in research. Despite strong interest in such results, they found multiple barriers to their effective use to improve health.

With the progression of genetic technologies, it is important to understand not only what technologies are available but also the range of results that they provide and how to interpret those results. From positive and negative results to secondary and novel findings, what information can these provide to patients and researchers/clinicians? Using anonymized clinical reports, the speakers will address this important next step in genetic technologies.

Dr. Tianyu Zhang from Carnegie Mellon University will discuss a new polygenic score framework and how it may benefit underrepresented populations..

Season 3, Voices in Genomics, with Farren Briggs, PhD, ScM.

Season Three of Genetically Speaking